Dashboard
Manage Tickers

BDXBECTON DICKINSON & CO

NYSE bd.com


$ 237.23 $ 5.50 (2.37 %)    

Monday, 09-Sep-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 237.22
$ 233.09
$ 237.15 x 100
$ 237.21 x 100
$ 233.08 - $ 238.98
$ 217.86 - $ 265.20
1,429,257
na
68.57B
$ 0.44
$ 48.53
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-01-2024 06-30-2024 10-Q
2 05-02-2024 03-31-2024 10-Q
3 02-01-2024 12-31-2023 10-Q
4 11-21-2023 09-30-2023 10-K
5 08-03-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 02-02-2023 12-31-2022 10-Q
8 11-22-2022 09-30-2022 10-K
9 08-04-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-03-2022 12-31-2021 10-Q
12 11-24-2021 09-30-2021 10-K
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-04-2021 12-31-2020 10-Q
16 11-25-2020 09-30-2020 10-K
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-06-2020 12-31-2019 10-Q
20 11-27-2019 09-30-2019 10-K
21 08-06-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-05-2019 12-31-2018 10-Q
24 11-21-2018 09-30-2018 10-K
25 08-02-2018 06-30-2018 10-Q
26 05-03-2018 03-31-2018 10-Q
27 02-06-2018 12-31-2017 10-Q
28 11-22-2017 09-30-2017 10-K
29 08-03-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-02-2017 12-31-2016 10-Q
32 11-23-2016 09-30-2016 10-K
33 08-04-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-05-2016 12-31-2015 10-Q
36 11-25-2015 09-30-2015 10-K
37 08-06-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 02-06-2015 12-31-2014 10-Q
40 11-26-2014 09-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bdx---analyzing-becton-dickinsons-short-interest
(BDX) - Analyzing Becton Dickinson's Short...
08/23/2024 16:15:23

looking-into-becton-dickinsons-recent-short-interest
Looking Into Becton Dickinson's Recent Sho...
08/07/2024 15:30:24

raymond-james-maintains-outperform-on-becton-dickinson-lowers-price-target-to-270
Raymond James Maintains Outperform on Bect...
08/02/2024 17:47:29

Raymond James analyst Jayson Bedford maintains Becton Dickinson (NYSE:BDX) with a Outperform and lowers the price target fro...

8-health-care-stocks-with-whale-alerts-in-todays-session
8 Health Care Stocks With Whale Alerts In ...
08/01/2024 17:35:24

bd-sees-fy24-adj-eps-1305-1315-vs-1304-est-adj-revenues-201b-202b
BD Sees FY24 Adj. EPS $13.05-$13.15 vs $13...
08/01/2024 10:33:20

becton-dickinson-q3-2024-adj-eps-350-beats-331-estimate-sales-4990b-miss-5076b-estimate
Becton, Dickinson Q3 2024 Adj. EPS $3.50 B...
08/01/2024 10:32:14

Becton, Dickinson (NYSE:BDX) reported quarterly earnings of $3.50 per share which beat the analyst consensus estimate of $3.31 ...

key-takeaways-from-becton-dickinson-analyst-ratings
Key Takeaways From Becton Dickinson Analys...
07/26/2024 16:01:13

stifel-maintains-buy-on-becton-dickinson-raises-price-target-to-280
Stifel Maintains Buy on Becton Dickinson, ...
07/26/2024 14:52:54

Stifel analyst Rick Wise maintains Becton Dickinson (NYSE:BDX) with a Buy and raises the price target from $270 to $280.

Core News & Articles
BD, Quest Diagnostics Partner To Develop C...
07/25/2024 11:02:30

The joint offerings will range from exploratory panel development to the manufacturing and distribution of FDA-approved diagnos...

cdc-says-disruptions-in-availability-of-becton-dickinson-bactec-blood-culture-bottles-blood-culture-bottles-issuing-health-alert-network-to-inform-critical-shortage-of-becton-dickinson-bactec-blood-culture-media-bottles-becton-dickinson-bactec-shortage-has-potential-to-disrupt-patient-care-by-leading-to-delays-in-diagnosis-misdiagnosis-or-other-challenges
CDC Says Disruptions In Availability Of Be...
07/23/2024 19:24:20

- Reuters

insulin-device-maker-embecta-weighs-sale-after-70-share-decline-following-becton-dickinson-spin-off
Insulin Device Maker Embecta Weighs Sale A...
07/23/2024 19:05:41

Embecta is exploring a potential sale after a nearly 70% drop in share price since its spin-off from Becton Dickinson. The comp...

looking-into-becton-dickinsons-recent-short-interest
Looking Into Becton Dickinson's Recent Sho...
07/17/2024 16:00:20

unitedhealth-edwards-lifesciences-first-citizens-bank-and-more-cnbcs-final-trades
UnitedHealth, Edwards Lifesciences, First ...
07/11/2024 12:40:27

UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a...

citigroup-maintains-neutral-on-becton-dickinson-lowers-price-target-to-255
Citigroup Maintains Neutral on Becton Dick...
07/11/2024 01:00:57

Citigroup analyst Joanna Wiensch maintains Becton Dickinson (NYSE:BDX) with a Neutral and lowers the price target from $260 ...

bd-committed-to-global-health-mitigating-blood-culture-vial-supplier-issue-with-fda-collaboration-rapid-production-and-restarting-glass-vial-production-manual-allocation-to-prioritize-clinical-needs-no-material-financial-impact-expected
BD Committed To Global Health; Mitigating ...
07/10/2024 16:15:07

fda-says--aware-that-us-is-experiencing-interruptions-in-the-supply-of-bd-bactec-blood-culture-media-bottles-because-of-recent-supplier-issues
FDA Says Aware That U.S. Is Experiencing ...
07/10/2024 15:17:13

- Reuters

becton-dickinson-says-it-has-surpassed-its-scope-1-and-2-science-based-greenhouse-gas-ghg-emissions-reduction-targets-for-fy-2023-by-5-percentage-points
Becton, Dickinson Says It Has Surpassed It...
07/10/2024 10:53:58

 This furthers the company's progress toward its goal to reach net zero GHG emissions across its value chain by FY 2050

evercore-isi-group-maintains-outperform-on-becton-dickinson-lowers-price-target-to-285
Evercore ISI Group Maintains Outperform on...
07/02/2024 15:02:14

Evercore ISI Group analyst Vijay Kumar maintains Becton Dickinson (NYSE:BDX) with a Outperform and lowers the price target f...

bd-has-commercially-launched-new-single-cell-research-tool-to-help-scientists-better-understand-how-molecular-machinery-within-a-cell-functions-and-it-regulates-changes-that-can-lead-to-cancer-and-other-diseases
BD Has Commercially Launched New Single-ce...
06/26/2024 10:46:57

peering-into-becton-dickinsons-recent-short-interest
Peering Into Becton Dickinson's Recent Sho...
06/10/2024 14:15:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION